{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:20:38Z","timestamp":1787908838138,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.7759\/cureus.38540","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T15:32:13Z","timestamp":1683214333000},"source":"Crossref","is-referenced-by-count":4,"title":["Three Consecutive Cases of Ocular Polyhexamethylene Biguanide (PHMB) Toxicity Due to Compounding Error"],"prefix":"10.7759","author":[{"given":"Nikunj V","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umang","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanil","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.1.27","article-title":"Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii","volume":"46","author":"Turner NA","year":"2000","unstructured":"Turner NA, Russell AD, Furr JR, Lloyd D. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii. J Antimicrob Chemother. 2000, 46:27-34. 10.1093\/jac\/46.1.27","journal-title":"J Antimicrob Chemother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314485","article-title":"Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases","volume":"104","author":"Papa V","year":"2020","unstructured":"Papa V, Rama P, Radford C, Minassian DC, Dart JK. Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases. Br J Ophthalmol. 2020, 104:575-81. 10.1136\/bjophthalmol-2019-314485","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.08.040","article-title":"Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis","volume":"145","author":"Lim N","year":"2008","unstructured":"Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol. 2008, 145:130-5. 10.1016\/j.ajo.2007.08.040","journal-title":"Am J Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(88)90837-9","article-title":"Corneal edema related to accidental hibiclens exposure","volume":"106","author":"Phinney RB","year":"1988","unstructured":"Phinney RB, Mondino BJ, Hofbauer JD, et al.. Corneal edema related to accidental hibiclens exposure. Am J Ophthalmol. 1988, 106:210-5. 10.1016\/0002-9394(88)90837-9","journal-title":"Am J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318218237e","article-title":"Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions","volume":"31","author":"Shigeyasu C","year":"2012","unstructured":"Shigeyasu C, Shimazaki J. Ocular surface reconstruction after exposure to high concentrations of antiseptic solutions. Cornea. 2012, 31:59-65. 10.1097\/ICO.0b013e318218237e","journal-title":"Cornea"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000822","article-title":"Chlorhexidine keratitis: safety of chlorhexidine as a facial antiseptic","volume":"43","author":"Steinsapir KD","year":"2017","unstructured":"Steinsapir KD, Woodward JA. Chlorhexidine keratitis: safety of chlorhexidine as a facial antiseptic. Dermatol Surg. 2017, 43:1-6. 10.1097\/DSS.0000000000000822","journal-title":"Dermatol Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(92)31994-3","article-title":"Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide","volume":"99","author":"Larkin DF","year":"1992","unstructured":"Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology. 1992, 99:185-191. 10.1016\/s0161-6420(92)31994-3","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00237.x","article-title":"Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?","volume":"82","author":"Ehlers N","year":"2004","unstructured":"Ehlers N, Hjortdal J. Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?. Acta Ophthalmol Scand. 2004, 82:228-31. 10.1111\/j.1600-0420.2004.00237.x","journal-title":"Acta Ophthalmol Scand"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.05.054","article-title":"Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis","volume":"115","author":"Herz NL","year":"2008","unstructured":"Herz NL, Matoba AY, Wilhelmus KR. Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis. Ophthalmology. 2008, 115:866-9. 10.1016\/j.ophtha.2007.05.054","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31805b7e8e","article-title":"Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine","volume":"26","author":"Lee JE","year":"2007","unstructured":"Lee JE, Oum BS, Choi HY, Yu HS, Lee JS. Cysticidal effect on acanthamoeba and toxicity on human keratocytes by polyhexamethylene biguanide and chlorhexidine. Cornea. 2007, 26:736-41. 10.1097\/ICO.0b013e31805b7e8e","journal-title":"Cornea"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2018.1447674","article-title":"The effect of antiamoebic agents on viability, proliferation and migration of human epithelial cells, keratocytes and endothelial cells, in vitro","volume":"43","author":"Shi L","year":"2018","unstructured":"Shi L, Stachon T, Seitz B, Wagenpfeil S, Langenbucher A, Szentm\u00e1ry N. The effect of antiamoebic agents on viability, proliferation and migration of human epithelial cells, keratocytes and endothelial cells, in vitro. Curr Eye Res. 2018, 43:725-33. 10.1080\/02713683.2018.1447674","journal-title":"Curr Eye Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-11990","article-title":"Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity","volume":"54","author":"Mafra CS","year":"2013","unstructured":"Mafra CS, Carrijo-Carvalho LC, Chudzinski-Tavassi AM, Taguchi FM, Foronda AS, Carvalho FR, de Freitas D. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity. Invest Ophthalmol Vis Sci. 2013, 54:6363-72. 10.1167\/iovs.13-11990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref13","unstructured":"Orphan drug for Acanthamoeba keratitis. (2022). Accessed. October 19, 2020: https:\/\/cordis.europa.eu\/project\/id\/305661\/reporting.."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.09.035","article-title":"Opinion of the scientific committee on consumer safety (SCCS) - 2nd revision of the safety of the use of poly(hexamethylene) biguanide hydrochloride or polyaminopropyl biguanide (PHMB) in cosmetic products","volume":"73","author":"Bernauer U","year":"2015","unstructured":"Bernauer U. Opinion of the scientific committee on consumer safety (SCCS) - 2nd revision of the safety of the use of poly(hexamethylene) biguanide hydrochloride or polyaminopropyl biguanide (PHMB) in cosmetic products. Regul Toxicol Pharmacol. 2015, 73:885-6. 10.1016\/j.yrtph.2015.09.035","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2019.11.012","article-title":"Safety of intrastromal injection of polyhexamethylene biguanide and propamidine isethionate in a rabbit model","volume":"22","author":"Lim CC","year":"2020","unstructured":"Lim CC, Peng IC, Huang YH. Safety of intrastromal injection of polyhexamethylene biguanide and propamidine isethionate in a rabbit model. J Adv Res. 2020, 22:1-6. 10.1016\/j.jare.2019.11.012","journal-title":"J Adv Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0140","article-title":"Failure of Acanthamoeba castellanii to produce intraocular infections","volume":"46","author":"Clarke DW","year":"2005","unstructured":"Clarke DW, Alizadeh H, Niederkorn JY. Failure of Acanthamoeba castellanii to produce intraocular infections. Invest Ophthalmol Vis Sci. 2005, 46:2472-8. 10.1167\/iovs.05-0140","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(01)00765-5","article-title":"Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature","volume":"108","author":"Moshari A","year":"2001","unstructured":"Moshari A, McLean IW, Dodds MT, Damiano RE, McEvoy PL. Chorioretinitis after keratitis caused by Acanthamoeba: case report and review of the literature. Ophthalmology. 2001, 108:2232-6. 10.1016\/s0161-6420(01)00765-5","journal-title":"Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.2376","article-title":"Successful monitoring and treatment of intraocular dissemination of acanthamoeba","volume":"130","author":"Arnalich-Montiel F","year":"2012","unstructured":"Arnalich-Montiel F, Mart\u00edn-Navarro CM, Ali\u00f3 JL, et al.. Successful monitoring and treatment of intraocular dissemination of acanthamoeba. Arch Ophthalmol. 2012, 130:1474-5. 10.1001\/archophthalmol.2012.2376","journal-title":"Arch Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000323","article-title":"Acanthamoeba endophthalmitis after recurrent keratitis and nodular scleritis","volume":"11","author":"Mammo Z","year":"2017","unstructured":"Mammo Z, Almeida DR, Cunningham MA, Chin EK, Mahajan VB. Acanthamoeba endophthalmitis after recurrent keratitis and nodular scleritis. Retin Cases Brief Rep. 2017, 11:180-2. 10.1097\/ICB.0000000000000323","journal-title":"Retin Cases Brief Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002289","article-title":"Fulminant Acanthamoeba endophthalmitis after cataract surgery - a case report","volume":"39","author":"Raghavan A","year":"2020","unstructured":"Raghavan A, Veerappan S, Rangarajan V, et al.. Fulminant Acanthamoeba endophthalmitis after cataract surgery - a case report. Cornea. 2020, 39:1055-8. 10.1097\/ICO.0000000000002289","journal-title":"Cornea"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/153045-three-consecutive-cases-of-ocular-polyhexamethylene-biguanide-phmb-toxicity-due-to-compounding-error","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:16Z","timestamp":1707508696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/153045-three-consecutive-cases-of-ocular-polyhexamethylene-biguanide-phmb-toxicity-due-to-compounding-error"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.38540","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}